A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...

Universal CAR T cells produce rapid remissions and enable allogeneic stem cell transplants in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.

The Cell Therapy Technologies Market is witnessing strong momentum driven by the rising prevalence of chronic diseases, growing adoption of personalized medicine, and continuous advancements in cell ...

Hyundai Motor Company has recently announced the introduction of the Hyundai Elantra N TCR sedan in one of the most popular ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced a research program under its strategic collaboration with Pfizer whereby Flagship-founded ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced a research program under its strategic collaboration with Pfizer whereby Flagship-founded ...

A new class of engineered extracellular vesicles induces antigen-specific regulatory T cells, offering a targeted strategy ...

The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...